chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal X-ray, Abdominal discomfort, Alanine aminotransferase normal, Alcohol use, Alcohol withdrawal syndrome
Clinical narrative: Pfizer Dose 1 4/13/21 (Er8732) Pfizer Dose 2 5/5/21 (ER8736) Pfizer Dose 3 1/11/22 (FH8027) COVID Positive 3/23/22  3/23/22: Patient is a 65-year-old female with past medical history of alcoholism, cirrhosis, chronic hepatitis C, rheumatoid arthritis, spinal stenosis, and history of smoking.  She presented to ED on 03/23/2022 after having an alcohol withdrawal seizure at home.  This is her 5th or 6th alcohol withdrawal seizure in total.  She has been unable to drink as much alcohol the last few days as her stomach has been upset.  Her last alcoholic drink was yesterday.  She has been vomiting recently.  No blood in her vomit.  No blood in her stools or dark stools.  She denies history of being told that she has esophageal varices.  She otherwise denies fever, chills, sweats.  No chest pain or shortness of breath.  After her seizure, her significant other brought her to the emergency department. Her blood pressure was elevated on arrival.  She was also mildly tachycardic.  Abdominal x-ray showed a moderate amount of gas and stool throughout the colon and rectum but was otherwise unremarkable.  She denies any abdominal pain so CT was held.  Her lab work was notable for creatinine of 1.23 which is actually about her baseline.  ALT was 36 and AST was 119.  Total bilirubin 2.5.  Lactic acid was 10.6. Her CBC was unremarkable.  Patient was administered Benadryl, morphine, Zofran, Phenergan, and normal saline, and thiamine in the ED.  She was admitted for further management of her alcohol withdrawal.  The patient wants to get sober.  She has previously been able to stay sober for about 6 months, but relapsed when her mom got sick.  She does not want to pursue inpatient treatment facility for her alcoholism.  She feels that she will be okay at home with her significant other as she does feel she has support at home.  She did try to smoke some marijuana to settle her stomach, but otherwise denies any illicit drug use.  No current smoking history.  Her family history was reviewed and is noncontributory.  3/25/22: The patient was admitted with alcohol withdrawal seizure, had recurrent episodes of alcohol withdrawal seizures, and actually she is on Keppra.  Unfortunately, patient continues to drink.  She was admitted, monitored on a CIWA scale.  Patient was seen and examined on the day of discharge.  She was awake, alert, and oriented.  Not exhibiting any alcohol withdrawal symptoms.  She had a slight fever.  She had a mild fever overnight. Otherwise, no source of infection other than her COVID-19 positive test, no respiratory symptoms, no difficulty breathing nor requiring any oxygen. She was instructed to self isolate at home for 10 days.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Alcoholic seizure, Aspartate aminotransferase increased, Blood bilirubin increased, Blood creatinine increased, Blood lactic acid
Clinical narrative: Pfizer Dose 1 4/13/21 (Er8732) Pfizer Dose 2 5/5/21 (ER8736) Pfizer Dose 3 1/11/22 (FH8027) COVID Positive 3/23/22  3/23/22: Patient is a 65-year-old female with past medical history of alcoholism, cirrhosis, chronic hepatitis C, rheumatoid arthritis, spinal stenosis, and history of smoking.  She presented to ED on 03/23/2022 after having an alcohol withdrawal seizure at home.  This is her 5th or 6th alcohol withdrawal seizure in total.  She has been unable to drink as much alcohol the last few days as her stomach has been upset.  Her last alcoholic drink was yesterday.  She has been vomiting recently.  No blood in her vomit.  No blood in her stools or dark stools.  She denies history of being told that she has esophageal varices.  She otherwise denies fever, chills, sweats.  No chest pain or shortness of breath.  After her seizure, her significant other brought her to the emergency department. Her blood pressure was elevated on arrival.  She was also mildly tachycardic.  Abdominal x-ray showed a moderate amount of gas and stool throughout the colon and rectum but was otherwise unremarkable.  She denies any abdominal pain so CT was held.  Her lab work was notable for creatinine of 1.23 which is actually about her baseline.  ALT was 36 and AST was 119.  Total bilirubin 2.5.  Lactic acid was 10.6. Her CBC was unremarkable.  Patient was administered Benadryl, morphine, Zofran, Phenergan, and normal saline, and thiamine in the ED.  She was admitted for further management of her alcohol withdrawal.  The patient wants to get sober.  She has previously been able to stay sober for about 6 months, but relapsed when her mom got sick.  She does not want to pursue inpatient treatment facility for her alcoholism.  She feels that she will be okay at home with her significant other as she does feel she has support at home.  She did try to smoke some marijuana to settle her stomach, but otherwise denies any illicit drug use.  No current smoking history.  Her family history was reviewed and is noncontributory.  3/25/22: The patient was admitted with alcohol withdrawal seizure, had recurrent episodes of alcohol withdrawal seizures, and actually she is on Keppra.  Unfortunately, patient continues to drink.  She was admitted, monitored on a CIWA scale.  Patient was seen and examined on the day of discharge.  She was awake, alert, and oriented.  Not exhibiting any alcohol withdrawal symptoms.  She had a slight fever.  She had a mild fever overnight. Otherwise, no source of infection other than her COVID-19 positive test, no respiratory symptoms, no difficulty breathing nor requiring any oxygen. She was instructed to self isolate at home for 10 days.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, COVID-19, Flatulence, Full blood count normal, Pyrexia
Clinical narrative: Pfizer Dose 1 4/13/21 (Er8732) Pfizer Dose 2 5/5/21 (ER8736) Pfizer Dose 3 1/11/22 (FH8027) COVID Positive 3/23/22  3/23/22: Patient is a 65-year-old female with past medical history of alcoholism, cirrhosis, chronic hepatitis C, rheumatoid arthritis, spinal stenosis, and history of smoking.  She presented to ED on 03/23/2022 after having an alcohol withdrawal seizure at home.  This is her 5th or 6th alcohol withdrawal seizure in total.  She has been unable to drink as much alcohol the last few days as her stomach has been upset.  Her last alcoholic drink was yesterday.  She has been vomiting recently.  No blood in her vomit.  No blood in her stools or dark stools.  She denies history of being told that she has esophageal varices.  She otherwise denies fever, chills, sweats.  No chest pain or shortness of breath.  After her seizure, her significant other brought her to the emergency department. Her blood pressure was elevated on arrival.  She was also mildly tachycardic.  Abdominal x-ray showed a moderate amount of gas and stool throughout the colon and rectum but was otherwise unremarkable.  She denies any abdominal pain so CT was held.  Her lab work was notable for creatinine of 1.23 which is actually about her baseline.  ALT was 36 and AST was 119.  Total bilirubin 2.5.  Lactic acid was 10.6. Her CBC was unremarkable.  Patient was administered Benadryl, morphine, Zofran, Phenergan, and normal saline, and thiamine in the ED.  She was admitted for further management of her alcohol withdrawal.  The patient wants to get sober.  She has previously been able to stay sober for about 6 months, but relapsed when her mom got sick.  She does not want to pursue inpatient treatment facility for her alcoholism.  She feels that she will be okay at home with her significant other as she does feel she has support at home.  She did try to smoke some marijuana to settle her stomach, but otherwise denies any illicit drug use.  No current smoking history.  Her family history was reviewed and is noncontributory.  3/25/22: The patient was admitted with alcohol withdrawal seizure, had recurrent episodes of alcohol withdrawal seizures, and actually she is on Keppra.  Unfortunately, patient continues to drink.  She was admitted, monitored on a CIWA scale.  Patient was seen and examined on the day of discharge.  She was awake, alert, and oriented.  Not exhibiting any alcohol withdrawal symptoms.  She had a slight fever.  She had a mild fever overnight. Otherwise, no source of infection other than her COVID-19 positive test, no respiratory symptoms, no difficulty breathing nor requiring any oxygen. She was instructed to self isolate at home for 10 days.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Substance use, Tachycardia, Vomiting
Clinical narrative: Pfizer Dose 1 4/13/21 (Er8732) Pfizer Dose 2 5/5/21 (ER8736) Pfizer Dose 3 1/11/22 (FH8027) COVID Positive 3/23/22  3/23/22: Patient is a 65-year-old female with past medical history of alcoholism, cirrhosis, chronic hepatitis C, rheumatoid arthritis, spinal stenosis, and history of smoking.  She presented to ED on 03/23/2022 after having an alcohol withdrawal seizure at home.  This is her 5th or 6th alcohol withdrawal seizure in total.  She has been unable to drink as much alcohol the last few days as her stomach has been upset.  Her last alcoholic drink was yesterday.  She has been vomiting recently.  No blood in her vomit.  No blood in her stools or dark stools.  She denies history of being told that she has esophageal varices.  She otherwise denies fever, chills, sweats.  No chest pain or shortness of breath.  After her seizure, her significant other brought her to the emergency department. Her blood pressure was elevated on arrival.  She was also mildly tachycardic.  Abdominal x-ray showed a moderate amount of gas and stool throughout the colon and rectum but was otherwise unremarkable.  She denies any abdominal pain so CT was held.  Her lab work was notable for creatinine of 1.23 which is actually about her baseline.  ALT was 36 and AST was 119.  Total bilirubin 2.5.  Lactic acid was 10.6. Her CBC was unremarkable.  Patient was administered Benadryl, morphine, Zofran, Phenergan, and normal saline, and thiamine in the ED.  She was admitted for further management of her alcohol withdrawal.  The patient wants to get sober.  She has previously been able to stay sober for about 6 months, but relapsed when her mom got sick.  She does not want to pursue inpatient treatment facility for her alcoholism.  She feels that she will be okay at home with her significant other as she does feel she has support at home.  She did try to smoke some marijuana to settle her stomach, but otherwise denies any illicit drug use.  No current smoking history.  Her family history was reviewed and is noncontributory.  3/25/22: The patient was admitted with alcohol withdrawal seizure, had recurrent episodes of alcohol withdrawal seizures, and actually she is on Keppra.  Unfortunately, patient continues to drink.  She was admitted, monitored on a CIWA scale.  Patient was seen and examined on the day of discharge.  She was awake, alert, and oriented.  Not exhibiting any alcohol withdrawal symptoms.  She had a slight fever.  She had a mild fever overnight. Otherwise, no source of infection other than her COVID-19 positive test, no respiratory symptoms, no difficulty breathing nor requiring any oxygen. She was instructed to self isolate at home for 10 days.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Acute kidney injury, Alanine aminotransferase increased, Anion gap, Asthenia
Clinical narrative: Moderna Dose 1 9/15/21 (053E21A) COVID Positive 2/17/22  2/17/22: Patient is a 34 year old male patient with a past medical history of Gout, Seasonal allergies was admitted from facility with Diabetic Ketoacidosis. Pt was seen by his PCP today, lab and xray was done, was told to go to ED . On admission blood glucose was 1176. Patient stated that he has been having nausea, vomiting for the past 3 weeks. He stated that he was able to drink only Gatorade drinks and could not keep down any food. Associated symptoms include increased urination and increased thirst. He also complains on mild abdominal pain level 5 out of 10. He did not have any bowel movements for 5 days.  He denies any diarrhea, fevers. Denies any chest pain, shortness of breath, dizziness.  Vital signs on admission blood pressure 158/89, HR 110, pulse ox 98% on room air. Laboratory findings significant for Metabolic acidosis, acute kidney injury BUN 39, Creat 1.49, Na 128mmol, Potassium 6.2, AGAP 29, ALT 56, Mg 3.1, Phos. 5.1, ketonuria 40. Patient admitted to ICU and started on insulin gtt.  2/22/22: Patient is a 34-year-old male with past medical history of gout, non alcoholic fatty liver disease, and smoking.  He presented on 02/17/2022 after being sent to the ER by his PCP.  He had been evaluated by his PCP for nausea, increased thirst, and increased urination.  His blood glucose was greater than 1000. In the emergency department, patient was diagnosed with DKA.  He had no known history of diabetes at the time.  He was placed on GlucoStabilizer protocol and admitted to the ICU.  He progressed well.  His COVID-19 PCR was positive on arrival, but he was never hypoxic.  He was complaining of some shortness of breath, cough, and generalized weakness at the time that his COVID-19 PCR resulted, so he was placed on remdesivir.  He received 2 doses.  This was discontinued when his liver enzymes were later found to be elevated in the 200 range.  His elevated liver enzymes were felt to be multifactorial due to his DKA, COVID-19 infection, initiation of insulin, and remdesivir exposure.  We discussed the importance of abstaining from alcohol for the time being to help prevent further damage to his liver and prevent complications with blood sugar management.  He will need follow-up on his liver enzymes as an outpatient. Patient received diabetic Education while in the hospital and we worked towards finding an appropriate insulin regimen.  Patient was discharged on 02/22/2022 to continue his medications as reconciled and follow-up with his primary care provider.  Of note, the patient felt his gout was worse recently and was requesting prescriptions for both allopurinol and colchicine as he was previously taking this and was pain free.  These prescriptions were sent to pharmacy.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Blood creatinine increased, Blood glucose increased, Blood magnesium increased, Blood phosphorus increased, Blood potassium increased
Clinical narrative: Moderna Dose 1 9/15/21 (053E21A) COVID Positive 2/17/22  2/17/22: Patient is a 34 year old male patient with a past medical history of Gout, Seasonal allergies was admitted from facility with Diabetic Ketoacidosis. Pt was seen by his PCP today, lab and xray was done, was told to go to ED . On admission blood glucose was 1176. Patient stated that he has been having nausea, vomiting for the past 3 weeks. He stated that he was able to drink only Gatorade drinks and could not keep down any food. Associated symptoms include increased urination and increased thirst. He also complains on mild abdominal pain level 5 out of 10. He did not have any bowel movements for 5 days.  He denies any diarrhea, fevers. Denies any chest pain, shortness of breath, dizziness.  Vital signs on admission blood pressure 158/89, HR 110, pulse ox 98% on room air. Laboratory findings significant for Metabolic acidosis, acute kidney injury BUN 39, Creat 1.49, Na 128mmol, Potassium 6.2, AGAP 29, ALT 56, Mg 3.1, Phos. 5.1, ketonuria 40. Patient admitted to ICU and started on insulin gtt.  2/22/22: Patient is a 34-year-old male with past medical history of gout, non alcoholic fatty liver disease, and smoking.  He presented on 02/17/2022 after being sent to the ER by his PCP.  He had been evaluated by his PCP for nausea, increased thirst, and increased urination.  His blood glucose was greater than 1000. In the emergency department, patient was diagnosed with DKA.  He had no known history of diabetes at the time.  He was placed on GlucoStabilizer protocol and admitted to the ICU.  He progressed well.  His COVID-19 PCR was positive on arrival, but he was never hypoxic.  He was complaining of some shortness of breath, cough, and generalized weakness at the time that his COVID-19 PCR resulted, so he was placed on remdesivir.  He received 2 doses.  This was discontinued when his liver enzymes were later found to be elevated in the 200 range.  His elevated liver enzymes were felt to be multifactorial due to his DKA, COVID-19 infection, initiation of insulin, and remdesivir exposure.  We discussed the importance of abstaining from alcohol for the time being to help prevent further damage to his liver and prevent complications with blood sugar management.  He will need follow-up on his liver enzymes as an outpatient. Patient received diabetic Education while in the hospital and we worked towards finding an appropriate insulin regimen.  Patient was discharged on 02/22/2022 to continue his medications as reconciled and follow-up with his primary care provider.  Of note, the patient felt his gout was worse recently and was requesting prescriptions for both allopurinol and colchicine as he was previously taking this and was pain free.  These prescriptions were sent to pharmacy.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Blood sodium decreased, Blood urea increased, COVID-19, Condition aggravated, Cough
Clinical narrative: Moderna Dose 1 9/15/21 (053E21A) COVID Positive 2/17/22  2/17/22: Patient is a 34 year old male patient with a past medical history of Gout, Seasonal allergies was admitted from facility with Diabetic Ketoacidosis. Pt was seen by his PCP today, lab and xray was done, was told to go to ED . On admission blood glucose was 1176. Patient stated that he has been having nausea, vomiting for the past 3 weeks. He stated that he was able to drink only Gatorade drinks and could not keep down any food. Associated symptoms include increased urination and increased thirst. He also complains on mild abdominal pain level 5 out of 10. He did not have any bowel movements for 5 days.  He denies any diarrhea, fevers. Denies any chest pain, shortness of breath, dizziness.  Vital signs on admission blood pressure 158/89, HR 110, pulse ox 98% on room air. Laboratory findings significant for Metabolic acidosis, acute kidney injury BUN 39, Creat 1.49, Na 128mmol, Potassium 6.2, AGAP 29, ALT 56, Mg 3.1, Phos. 5.1, ketonuria 40. Patient admitted to ICU and started on insulin gtt.  2/22/22: Patient is a 34-year-old male with past medical history of gout, non alcoholic fatty liver disease, and smoking.  He presented on 02/17/2022 after being sent to the ER by his PCP.  He had been evaluated by his PCP for nausea, increased thirst, and increased urination.  His blood glucose was greater than 1000. In the emergency department, patient was diagnosed with DKA.  He had no known history of diabetes at the time.  He was placed on GlucoStabilizer protocol and admitted to the ICU.  He progressed well.  His COVID-19 PCR was positive on arrival, but he was never hypoxic.  He was complaining of some shortness of breath, cough, and generalized weakness at the time that his COVID-19 PCR resulted, so he was placed on remdesivir.  He received 2 doses.  This was discontinued when his liver enzymes were later found to be elevated in the 200 range.  His elevated liver enzymes were felt to be multifactorial due to his DKA, COVID-19 infection, initiation of insulin, and remdesivir exposure.  We discussed the importance of abstaining from alcohol for the time being to help prevent further damage to his liver and prevent complications with blood sugar management.  He will need follow-up on his liver enzymes as an outpatient. Patient received diabetic Education while in the hospital and we worked towards finding an appropriate insulin regimen.  Patient was discharged on 02/22/2022 to continue his medications as reconciled and follow-up with his primary care provider.  Of note, the patient felt his gout was worse recently and was requesting prescriptions for both allopurinol and colchicine as he was previously taking this and was pain free.  These prescriptions were sent to pharmacy.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Diabetic ketoacidosis, Dyspnoea, Gout, Hepatic enzyme increased, Infrequent bowel movements
Clinical narrative: Moderna Dose 1 9/15/21 (053E21A) COVID Positive 2/17/22  2/17/22: Patient is a 34 year old male patient with a past medical history of Gout, Seasonal allergies was admitted from facility with Diabetic Ketoacidosis. Pt was seen by his PCP today, lab and xray was done, was told to go to ED . On admission blood glucose was 1176. Patient stated that he has been having nausea, vomiting for the past 3 weeks. He stated that he was able to drink only Gatorade drinks and could not keep down any food. Associated symptoms include increased urination and increased thirst. He also complains on mild abdominal pain level 5 out of 10. He did not have any bowel movements for 5 days.  He denies any diarrhea, fevers. Denies any chest pain, shortness of breath, dizziness.  Vital signs on admission blood pressure 158/89, HR 110, pulse ox 98% on room air. Laboratory findings significant for Metabolic acidosis, acute kidney injury BUN 39, Creat 1.49, Na 128mmol, Potassium 6.2, AGAP 29, ALT 56, Mg 3.1, Phos. 5.1, ketonuria 40. Patient admitted to ICU and started on insulin gtt.  2/22/22: Patient is a 34-year-old male with past medical history of gout, non alcoholic fatty liver disease, and smoking.  He presented on 02/17/2022 after being sent to the ER by his PCP.  He had been evaluated by his PCP for nausea, increased thirst, and increased urination.  His blood glucose was greater than 1000. In the emergency department, patient was diagnosed with DKA.  He had no known history of diabetes at the time.  He was placed on GlucoStabilizer protocol and admitted to the ICU.  He progressed well.  His COVID-19 PCR was positive on arrival, but he was never hypoxic.  He was complaining of some shortness of breath, cough, and generalized weakness at the time that his COVID-19 PCR resulted, so he was placed on remdesivir.  He received 2 doses.  This was discontinued when his liver enzymes were later found to be elevated in the 200 range.  His elevated liver enzymes were felt to be multifactorial due to his DKA, COVID-19 infection, initiation of insulin, and remdesivir exposure.  We discussed the importance of abstaining from alcohol for the time being to help prevent further damage to his liver and prevent complications with blood sugar management.  He will need follow-up on his liver enzymes as an outpatient. Patient received diabetic Education while in the hospital and we worked towards finding an appropriate insulin regimen.  Patient was discharged on 02/22/2022 to continue his medications as reconciled and follow-up with his primary care provider.  Of note, the patient felt his gout was worse recently and was requesting prescriptions for both allopurinol and colchicine as he was previously taking this and was pain free.  These prescriptions were sent to pharmacy.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Intensive care, Ketonuria, Laboratory test abnormal, Metabolic acidosis, Nausea
Clinical narrative: Moderna Dose 1 9/15/21 (053E21A) COVID Positive 2/17/22  2/17/22: Patient is a 34 year old male patient with a past medical history of Gout, Seasonal allergies was admitted from facility with Diabetic Ketoacidosis. Pt was seen by his PCP today, lab and xray was done, was told to go to ED . On admission blood glucose was 1176. Patient stated that he has been having nausea, vomiting for the past 3 weeks. He stated that he was able to drink only Gatorade drinks and could not keep down any food. Associated symptoms include increased urination and increased thirst. He also complains on mild abdominal pain level 5 out of 10. He did not have any bowel movements for 5 days.  He denies any diarrhea, fevers. Denies any chest pain, shortness of breath, dizziness.  Vital signs on admission blood pressure 158/89, HR 110, pulse ox 98% on room air. Laboratory findings significant for Metabolic acidosis, acute kidney injury BUN 39, Creat 1.49, Na 128mmol, Potassium 6.2, AGAP 29, ALT 56, Mg 3.1, Phos. 5.1, ketonuria 40. Patient admitted to ICU and started on insulin gtt.  2/22/22: Patient is a 34-year-old male with past medical history of gout, non alcoholic fatty liver disease, and smoking.  He presented on 02/17/2022 after being sent to the ER by his PCP.  He had been evaluated by his PCP for nausea, increased thirst, and increased urination.  His blood glucose was greater than 1000. In the emergency department, patient was diagnosed with DKA.  He had no known history of diabetes at the time.  He was placed on GlucoStabilizer protocol and admitted to the ICU.  He progressed well.  His COVID-19 PCR was positive on arrival, but he was never hypoxic.  He was complaining of some shortness of breath, cough, and generalized weakness at the time that his COVID-19 PCR resulted, so he was placed on remdesivir.  He received 2 doses.  This was discontinued when his liver enzymes were later found to be elevated in the 200 range.  His elevated liver enzymes were felt to be multifactorial due to his DKA, COVID-19 infection, initiation of insulin, and remdesivir exposure.  We discussed the importance of abstaining from alcohol for the time being to help prevent further damage to his liver and prevent complications with blood sugar management.  He will need follow-up on his liver enzymes as an outpatient. Patient received diabetic Education while in the hospital and we worked towards finding an appropriate insulin regimen.  Patient was discharged on 02/22/2022 to continue his medications as reconciled and follow-up with his primary care provider.  Of note, the patient felt his gout was worse recently and was requesting prescriptions for both allopurinol and colchicine as he was previously taking this and was pain free.  These prescriptions were sent to pharmacy.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Pollakiuria, SARS-CoV-2 test positive, Thirst, Vomiting, X-ray
Clinical narrative: Moderna Dose 1 9/15/21 (053E21A) COVID Positive 2/17/22  2/17/22: Patient is a 34 year old male patient with a past medical history of Gout, Seasonal allergies was admitted from facility with Diabetic Ketoacidosis. Pt was seen by his PCP today, lab and xray was done, was told to go to ED . On admission blood glucose was 1176. Patient stated that he has been having nausea, vomiting for the past 3 weeks. He stated that he was able to drink only Gatorade drinks and could not keep down any food. Associated symptoms include increased urination and increased thirst. He also complains on mild abdominal pain level 5 out of 10. He did not have any bowel movements for 5 days.  He denies any diarrhea, fevers. Denies any chest pain, shortness of breath, dizziness.  Vital signs on admission blood pressure 158/89, HR 110, pulse ox 98% on room air. Laboratory findings significant for Metabolic acidosis, acute kidney injury BUN 39, Creat 1.49, Na 128mmol, Potassium 6.2, AGAP 29, ALT 56, Mg 3.1, Phos. 5.1, ketonuria 40. Patient admitted to ICU and started on insulin gtt.  2/22/22: Patient is a 34-year-old male with past medical history of gout, non alcoholic fatty liver disease, and smoking.  He presented on 02/17/2022 after being sent to the ER by his PCP.  He had been evaluated by his PCP for nausea, increased thirst, and increased urination.  His blood glucose was greater than 1000. In the emergency department, patient was diagnosed with DKA.  He had no known history of diabetes at the time.  He was placed on GlucoStabilizer protocol and admitted to the ICU.  He progressed well.  His COVID-19 PCR was positive on arrival, but he was never hypoxic.  He was complaining of some shortness of breath, cough, and generalized weakness at the time that his COVID-19 PCR resulted, so he was placed on remdesivir.  He received 2 doses.  This was discontinued when his liver enzymes were later found to be elevated in the 200 range.  His elevated liver enzymes were felt to be multifactorial due to his DKA, COVID-19 infection, initiation of insulin, and remdesivir exposure.  We discussed the importance of abstaining from alcohol for the time being to help prevent further damage to his liver and prevent complications with blood sugar management.  He will need follow-up on his liver enzymes as an outpatient. Patient received diabetic Education while in the hospital and we worked towards finding an appropriate insulin regimen.  Patient was discharged on 02/22/2022 to continue his medications as reconciled and follow-up with his primary care provider.  Of note, the patient felt his gout was worse recently and was requesting prescriptions for both allopurinol and colchicine as he was previously taking this and was pain free.  These prescriptions were sent to pharmacy.
Age: 1.25
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Irritability, Pyrexia
Clinical narrative: fever onsetted 2pm 24th of June and lasted until 6am June 29th. Irritability and loss of apetite
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Influenza virus test, Malaise, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I woke up with a scratchy throat. Later that night I started feeling sick I knew I had a fever coming on so I took my temperature and it was 100.2 & later it was 101.4. So I took COVID-19 test & it was negative. I called my Dr. and was told to take EMERGEN C & rest. I went to urgent care and was tested again for COVID-19 and it was positive.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Streptococcus test, Throat irritation
Clinical narrative: I woke up with a scratchy throat. Later that night I started feeling sick I knew I had a fever coming on so I took my temperature and it was 100.2 & later it was 101.4. So I took COVID-19 test & it was negative. I called my Dr. and was told to take EMERGEN C & rest. I went to urgent care and was tested again for COVID-19 and it was positive.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Rotator cuff syndrome, X-ray limb abnormal
Clinical narrative: I developed calcific tendinitis in my left shoulder.   I saw orthopedic surgeon, on 6/15/22.  He diagnosed me after taking an X-Ray that showed calcific changes in my tendon.  I was treated with two steroid shots and received PT.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: No adverse event. I was advised by phone call from CDC VSafe that I could use this website to report symptoms of COVID19, but this appears to be only for reporting adverse events 2 weeks later I tested positive for COVID19. Symptoms were sore throat, runny nose, sneezing and mild fatigue. Symptoms resolved after 5 days.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Sneezing
Clinical narrative: No adverse event. I was advised by phone call from CDC VSafe that I could use this website to report symptoms of COVID19, but this appears to be only for reporting adverse events 2 weeks later I tested positive for COVID19. Symptoms were sore throat, runny nose, sneezing and mild fatigue. Symptoms resolved after 5 days.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Mydriasis, Slow speech
Clinical narrative: After the patient had received the vaccine she was asked to stay in the store for 15 minutes per policy, Patient stepped away, and once returned she said she did not feel good. The staff sat her down and was asked if needed to call her ambulance. Patient Declined. She called her husband who then picked her up. Patient said she felt dizzy and light-headed. The staff also noticed that her pupils were really big and she had a slow speech. We still insisted to call an ambulance but patient wanted to be with her husband.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Diarrhoea, Feeling abnormal, Impaired work ability
Clinical narrative: I tested positive for Covid-19 on 6/27/22. I think that I might have been overworked from some volunteer work because I started feeling bad as soon as I finished the work. I was vomiting, body aches, trembling chills, and loose stool. My wife called the clinic the next morning and my doctor prescribed PAXLOVID. I am still dealing with the symptoms at this time, but they are better than they were.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, SARS-CoV-2 test positive, Tremor, Vomiting
Clinical narrative: I tested positive for Covid-19 on 6/27/22. I think that I might have been overworked from some volunteer work because I started feeling bad as soon as I finished the work. I was vomiting, body aches, trembling chills, and loose stool. My wife called the clinic the next morning and my doctor prescribed PAXLOVID. I am still dealing with the symptoms at this time, but they are better than they were.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Fatigue, Feeling abnormal
Clinical narrative: My symptoms began progressively. I had a runny nose and a mild headache on about 06/11/2022 and 06/12/2022. Then I woke up with a raging headache on 06/13/2022 so I took a COVID-19 Test which came back positive. I was on a cruse ship at the time and contacted the medical department and they did a PCR which also came back positive. Other symptoms I experienced was that I lost my sense of taste and smell which still have not come completely back, I felt very fatigued and basically, I felt nasty.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: My symptoms began progressively. I had a runny nose and a mild headache on about 06/11/2022 and 06/12/2022. Then I woke up with a raging headache on 06/13/2022 so I took a COVID-19 Test which came back positive. I was on a cruse ship at the time and contacted the medical department and they did a PCR which also came back positive. Other symptoms I experienced was that I lost my sense of taste and smell which still have not come completely back, I felt very fatigued and basically, I felt nasty.
Age: 33.0
Sex: F
Vaccine: HEP
Symptoms: Electrocardiogram, Immunisation reaction, Laboratory test
Clinical narrative: Done in Health: Benadryl 25mg tablet, Epi 0.3mg IM, Sent ER.  ER per patient: Liquid Benadryl, Fluids, Labs and EKG
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure decreased, Condition aggravated, Malaise, Mast cell activation syndrome, Mental status changes
Clinical narrative: I generally did not feel well after my vaccination and my arm was sore for about a week. Mast Cell activation disorder has been flaring up more frequently since receiving the shot. I was receiving an IV infusion on 06/24/2022, where I then had a terrible mast cell reaction during my IV infusion. I was given steroids in my IV to counteract the reaction as quickly as possible. I was then just placed on observation and on Tuesday, I saw my primary care and they said I should have went to the ER. My blood pressure dropped very low and I was in an altered state of mind during the recovery period. I started to feel better on 06/29/2022 and am still recovering.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: I generally did not feel well after my vaccination and my arm was sore for about a week. Mast Cell activation disorder has been flaring up more frequently since receiving the shot. I was receiving an IV infusion on 06/24/2022, where I then had a terrible mast cell reaction during my IV infusion. I was given steroids in my IV to counteract the reaction as quickly as possible. I was then just placed on observation and on Tuesday, I saw my primary care and they said I should have went to the ER. My blood pressure dropped very low and I was in an altered state of mind during the recovery period. I started to feel better on 06/29/2022 and am still recovering.
Age: 1.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Pyrexia, Rash, Rash erythematous, Rash macular
Clinical narrative: The next day, he developed a fever on 6/26/2022 that continued until 6/27/2022. His fever got up to 101.8 at the highest. On 6/27/2022, he developed a rash that was in a couple of spots on his body. The rash progressed and spread all over. The rash was red with small botchy circles but not raised. On 6/29/2022 we took him to the doctor. The rash was worse on his stomach that looked like Rosacea but it looked different than on his face that looked more like hives. Today his rash looks better and it is resolving. He has also had Diarrhea since 6/26/2022 that has resolved today. The doctor did do a COVID-19 test that was negative.
Age: 1.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative
Clinical narrative: The next day, he developed a fever on 6/26/2022 that continued until 6/27/2022. His fever got up to 101.8 at the highest. On 6/27/2022, he developed a rash that was in a couple of spots on his body. The rash progressed and spread all over. The rash was red with small botchy circles but not raised. On 6/29/2022 we took him to the doctor. The rash was worse on his stomach that looked like Rosacea but it looked different than on his face that looked more like hives. Today his rash looks better and it is resolving. He has also had Diarrhea since 6/26/2022 that has resolved today. The doctor did do a COVID-19 test that was negative.
Age: 2.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, Rash papular
Clinical narrative: Rash (raised and red but not itchy) started on leg in AM of 6/29  but has spread over legs, buttocks' and chest on 6/30.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling, Hypersensitivity, Immunisation reaction, Lip swelling, Oral pruritus
Clinical narrative: I got the vaccine on October 27, 2021. On November 5 at about 01:00AM, I woke up with an itchy mouth and my face started to tingle. My lips, eyes, tongue, and throat started to swell up. I took some Benadryl as soon as I started to feel symptoms and monitored. The symptoms persisted despite the Benadryl, so we went to the  Emergency Department and we waited for 3 hours. They called me back and took my vitals and they agreed that it was an allergic reaction. I was not able to talk well, but my husband did tell them that I had a response to the 2nd Moderna vaccine with the overreaction in my arm. The doctor at the ER did not seem to think it was related in the moment. They gave me prednisone on site at 02:45AM. We left with a prescription for an epi pen and prednisone. We left after the symptoms had gone down and after the prednisone. I took prednisone for 2-3 days after. They did refer me to an allergy specialist, and I called my healthcare provider and they said it was most likely a response to the vaccine since there wasn?t anything to have an allergic reaction to. Along with my reaction to the other dose. I did not do further testing for the allergies, and I was told to call the CDC. I?m currently due for my next booster.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Pharyngeal swelling, Sleep disorder, Speech disorder, Swollen tongue
Clinical narrative: I got the vaccine on October 27, 2021. On November 5 at about 01:00AM, I woke up with an itchy mouth and my face started to tingle. My lips, eyes, tongue, and throat started to swell up. I took some Benadryl as soon as I started to feel symptoms and monitored. The symptoms persisted despite the Benadryl, so we went to the  Emergency Department and we waited for 3 hours. They called me back and took my vitals and they agreed that it was an allergic reaction. I was not able to talk well, but my husband did tell them that I had a response to the 2nd Moderna vaccine with the overreaction in my arm. The doctor at the ER did not seem to think it was related in the moment. They gave me prednisone on site at 02:45AM. We left with a prescription for an epi pen and prednisone. We left after the symptoms had gone down and after the prednisone. I took prednisone for 2-3 days after. They did refer me to an allergy specialist, and I called my healthcare provider and they said it was most likely a response to the vaccine since there wasn?t anything to have an allergic reaction to. Along with my reaction to the other dose. I did not do further testing for the allergies, and I was told to call the CDC. I?m currently due for my next booster.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Exposure to SARS-CoV-2, Headache, Malaise
Clinical narrative: My husband was exposed to a co-worker was positive for COVID-19, he developed symptoms. I tested four time and was negative until day 12 then I started getting symptoms. Runny nose, headaches, mild cough for maybe a day and a half. I waited to test again for another day it came back positive, I called to let my doctor know, they scheduled a telehealth visit where advised me to look for certain symptoms that may lead to long COVID-19.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: My husband was exposed to a co-worker was positive for COVID-19, he developed symptoms. I tested four time and was negative until day 12 then I started getting symptoms. Runny nose, headaches, mild cough for maybe a day and a half. I waited to test again for another day it came back positive, I called to let my doctor know, they scheduled a telehealth visit where advised me to look for certain symptoms that may lead to long COVID-19.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Asthenia, COVID-19, Cough, Fatigue
Clinical narrative: Starting 01/01/2022, I developed a scratchy throat, nasal drip and a slight cough. It was all contained within my sinuses. I had a lot of brain fog and felt extremely exhausted for 2 weeks. I had a mild fever but it was never high (101 was the highest it ever got). I tested positive with an at-home COVID-19 test on 01/03/2022. I contacted my doctor and they told me to alert the health department and to take whatever over the counter medications I would normally take for a cold to relieve symptoms. If it led to breathing issues/coughing, I was told to contact the office again, but that didn't happen. Due to my pre-existing asthma, my normal pulse oximeter would show 93% and during this event it varied between 87 -93%. It took about a month before my energy returned to normal. I started losing my hair in early march and I saw my doctor on 06/27/2022 who did a thyroid test to confirm it wasn't my thyroid. The test came back normal and the doctor told me it was likely due to stress from having COVID-19.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Pyrexia, SARS-CoV-2 test positive, Stress, Throat irritation
Clinical narrative: Starting 01/01/2022, I developed a scratchy throat, nasal drip and a slight cough. It was all contained within my sinuses. I had a lot of brain fog and felt extremely exhausted for 2 weeks. I had a mild fever but it was never high (101 was the highest it ever got). I tested positive with an at-home COVID-19 test on 01/03/2022. I contacted my doctor and they told me to alert the health department and to take whatever over the counter medications I would normally take for a cold to relieve symptoms. If it led to breathing issues/coughing, I was told to contact the office again, but that didn't happen. Due to my pre-existing asthma, my normal pulse oximeter would show 93% and during this event it varied between 87 -93%. It took about a month before my energy returned to normal. I started losing my hair in early march and I saw my doctor on 06/27/2022 who did a thyroid test to confirm it wasn't my thyroid. The test came back normal and the doctor told me it was likely due to stress from having COVID-19.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Thyroid function test normal, Upper-airway cough syndrome
Clinical narrative: Starting 01/01/2022, I developed a scratchy throat, nasal drip and a slight cough. It was all contained within my sinuses. I had a lot of brain fog and felt extremely exhausted for 2 weeks. I had a mild fever but it was never high (101 was the highest it ever got). I tested positive with an at-home COVID-19 test on 01/03/2022. I contacted my doctor and they told me to alert the health department and to take whatever over the counter medications I would normally take for a cold to relieve symptoms. If it led to breathing issues/coughing, I was told to contact the office again, but that didn't happen. Due to my pre-existing asthma, my normal pulse oximeter would show 93% and during this event it varied between 87 -93%. It took about a month before my energy returned to normal. I started losing my hair in early march and I saw my doctor on 06/27/2022 who did a thyroid test to confirm it wasn't my thyroid. The test came back normal and the doctor told me it was likely due to stress from having COVID-19.
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: The improper diluent (sterile water) was utilized to dilute the vaccine.  Reviewed with Pfizer as per CDC guidelines, who stated to follow CDC guidelines as mother was contacted and informed of CDC guidelines, "Contact the manufacturer for information on the stability of the vaccine. If the manufacturer does not have information to support the stability of the vaccine, repeat the dose immediately".
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Headache, Influenza like illness, Malaise, Pain
Clinical narrative: COVID-19 symptoms started on 05/15/22; tested positive on 05/16/22. Symptoms were body aches, headache, flu-like symptoms, runny nose, and congestion. I took vitamin c, d, zinc, and Paxlovid. Symptoms lasted for 2 weeks.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: COVID-19 symptoms started on 05/15/22; tested positive on 05/16/22. Symptoms were body aches, headache, flu-like symptoms, runny nose, and congestion. I took vitamin c, d, zinc, and Paxlovid. Symptoms lasted for 2 weeks.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Rash maculo-papular
Clinical narrative: developed macula-papular rash to extremities, torso, back, neck approx 48 hours after vaccination similar to prior rashes after Covid vaccines (Moderna and Pfizer vaccines).  Resolved after approx 48 hours
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Ear pain, Fatigue, Feeling abnormal
Clinical narrative: The symptoms started with a sore throat, I then developed fatigue, brain fog, sore muscles, shortness of breath, low but not critical 02 stats, ear pain, runny nose, my skin felt bruised all over my body. Symptoms started on the 30th and lasted the 5/6th of June.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Oropharyngeal pain, Oxygen saturation decreased, Pain of skin, Rhinorrhoea
Clinical narrative: The symptoms started with a sore throat, I then developed fatigue, brain fog, sore muscles, shortness of breath, low but not critical 02 stats, ear pain, runny nose, my skin felt bruised all over my body. Symptoms started on the 30th and lasted the 5/6th of June.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: The symptoms started with a sore throat, I then developed fatigue, brain fog, sore muscles, shortness of breath, low but not critical 02 stats, ear pain, runny nose, my skin felt bruised all over my body. Symptoms started on the 30th and lasted the 5/6th of June.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Loss of personal independence in daily activities, Mobility decreased, Multiple sclerosis relapse
Clinical narrative: Patient has multiple sclerosis. He received the vaccine Monday morning (6/27/22), said he was completely fine the rest of the day until bedtime. He said he could barely get into bed, had very limited mobility in bed throughout the night (rolling over), and he could barely get out of bed in the morning and needed assistance. All of this he described as abnormal. During the day on Tuesday (6/28), his symptoms improved, however, that evening, he experienced the same symptoms, and slept in his recliner rather than his bed. Since Wednesday morning, he said he has been feeling normal again. He described this event as an "MS exacerbation." He also said he did not change anything in his medication routine, and had no reaction to his first J&J COVID-19 vaccine.